Xcellerex Xcellerate technology
GPTKB entity
Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology
|
| gptkbp:associated_with |
increased yield
|
| gptkbp:basedOn |
modular design
|
| gptkbp:bornIn |
leading biotech firms
|
| gptkbp:compatibleWith |
various cell lines
|
| gptkbp:contributedTo |
the growth of the biotech industry
|
| gptkbp:developedBy |
gptkb:Xcellerex
|
| gptkbp:enables |
rapid scale-up
|
| gptkbp:enhances |
product quality
|
| gptkbp:facilitates |
continuous manufacturing
|
| gptkbp:features |
promotes sustainability.
enhances productivity supports regulatory compliance |
| gptkbp:hasPrograms |
biotech companies
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xcellerex Xcellerate technology
|
| gptkbp:improves |
process efficiency
|
| gptkbp:integration |
single-use systems
|
| gptkbp:is_a_key_component_of |
biopharmaceutical development
modern biomanufacturing |
| gptkbp:is_a_key_player_in |
the biopharmaceutical landscape
|
| gptkbp:is_a_model_for |
future biomanufacturing technologies
|
| gptkbp:is_a_platform_for |
collaborative research
enables innovation |
| gptkbp:is_a_popular_spot_for |
contract manufacturers
|
| gptkbp:is_a_resource_for |
manufacturers
bioprocess optimization quality assurance in production |
| gptkbp:is_a_source_of |
lab to production
|
| gptkbp:is_a_time_for |
scalable production
addresses industry challenges bioprocessing challenges |
| gptkbp:is_a_tool_for |
research and development
enhances operational efficiency |
| gptkbp:is_designed_to |
ease of use
meet regulatory standards |
| gptkbp:is_essential_for |
bioprocess technology
|
| gptkbp:is_featured_in |
biotechnology conferences
|
| gptkbp:is_known_for |
scalability
reducing contamination risks |
| gptkbp:is_part_of |
sustainable manufacturing practices
the future of biomanufacturing Xcellerex_product_portfolio |
| gptkbp:is_recognized_for |
industry experts
clinical settings cost-effectiveness its innovative approach |
| gptkbp:is_supported_by |
advanced analytics
|
| gptkbp:is_used_in |
pharmaceutical companies
gene therapy production |
| gptkbp:isFacilitatedBy |
innovation in drug development
|
| gptkbp:leadership |
flexible biomanufacturing solutions
|
| gptkbp:notableDrivers |
efficiency in production processes
|
| gptkbp:offers |
real-time monitoring
|
| gptkbp:products |
innovation in biotechnology
|
| gptkbp:provides |
flexibility in production
|
| gptkbp:reduces |
time to market
operational risks |
| gptkbp:suitableFor |
cell culture
protein production vaccine production |
| gptkbp:supports |
multiple product types
|
| gptkbp:usedFor |
biopharmaceutical manufacturing
|
| gptkbp:was_a_factor_in |
reducing costs
|
| gptkbp:was_a_response_to |
market demand for efficiency
|